News search results
The results from your search are listed below:
21 November 2019
Inducing labour at 41 weeks in low risk pregnancies is associated with a lower risk of newborn death compared with expectant management (a “wait and see” approach) until 42 weeks, suggests a trial published by The BMJ.
20 November 2019
A leaked status update on an independent maternity review into cases of serious and potentially serious concern at the Shrewsbury and Telford Hospitals NHS Trust has been published by The Independent newspaper and subsequently other media outlets.
29 October 2019
New resources for women affected by obstetric anal sphincter injury, or vaginal tearing during birth, have been developed and published by the Royal College of Obstetricians and Gynaecologists today.
22 October 2019
“Today marks a historic step in a long campaign to secure safe and compassionate abortion care for women in Northern Ireland," said Professor Lesley Regan, President of the RCOG.
10 October 2019
The RCOG has published consent advice and patient information for women offered a myomectomy or hysterectomy using morcellation, to reflect the latest emerging evidence.
25 September 2019
Women should be given the choice of a medical or surgical abortion and be able to refer themselves to abortion care services directly, says new clinical guidance published jointly by the RCOG and NICE today.
20 September 2019
The Royal College of Obstetricians and Gynaecologists is pleased to announce the next Vice Presidents of the RCOG.
12 September 2019
The National Maternity and Perinatal Audit is a major analysis of NHS maternity and neonatal services in Britain. Launched in 2016, it uses data collected by hospitals to evaluate a range of care processes and outcomes, and produces high-quality
4 September 2019
The Royal College of Obstetricians and Gynaecologists has appointed Baroness Tessa Blackstone as the first independent chair of its Trustee board.
30 August 2019
Joint Royal College of Obstetricians and Gynaecologists & British Menopause Society statement in response to the Lancet study on HRT use and breast cancer risk.